
Scientists identify a mutant #STAT3 protein in a patient with hyper-IgE syndrome, which forms dimers with wild-type STAT3 that have impaired transcriptional activity. @JoeMackie6 @Tangye_Lab @GarvanInstitute scim.ag/3UgIqNx

We are a research lab @GarvanInstitute trying to unravel the complexities of human immunology. One gene at a time.

Scientists identify a mutant #STAT3 protein in a patient with hyper-IgE syndrome, which forms dimers with wild-type STAT3 that have impaired transcriptional activity. @JoeMackie6 @Tangye_Lab @GarvanInstitute scim.ag/3UgIqNx

Latest paper from us. Led by @JoeMackie6. New insights into how novel variants in the N terminal domain of STAT3 can disrupt STAT3 function and cause human disease.
Scientists identify a mutant #STAT3 protein in a patient with hyper-IgE syndrome, which forms dimers with wild-type STAT3 that have impaired transcriptional activity. @JoeMackie6 @Tangye_Lab @GarvanInstitute scim.ag/3UgIqNx

‘Australia without migrant workers’ Who made this? 👏 Mandatory viewing for any fool who still doesn’t understand the implications of slamming the gates shut.

It was great to collaborator yet again with @ryangrui, many friends in the @casanova_lab, my long term collaborator @DrCindyMa, @GuerinAntoine6 to help bring this paper to fruition. Science really is amazing ! 🧬 🧪
1/ Delighted to share our paper in @JExpMed today, led by @IrisFagniez and @ryangrui, two trainees who have both recently started exciting new chapters in their careers: MD-PhD training at @harvardmed @MIT and Assistant Professorship at @bcmhouston! rupress.org/jem/article/223/…

Short clip from the full episode of Beyond the Noise #109 responding to Trump's latest executive order on vaccines:

Dan was a giant and he will be sorely missed. His discoveries will remain and his alumni will carry the torch.
We are saddened to announce that Dr Daniel Kastner, MD, PhD, a legendary, brilliant & kind-hearted physician and researcher passed away this Sunday. Dr Kastner will be greatly missed, but his impact is beyond measure, & everlasting. 🧡 issaid.org/news.html#29 #autoinflammatory

We have lost a true genius and such a kind and enthusiastic person 😢 RIP Dr Kastner
We are saddened to announce that Dr Daniel Kastner, MD, PhD, a legendary, brilliant & kind-hearted physician and researcher passed away this Sunday. Dr Kastner will be greatly missed, but his impact is beyond measure, & everlasting. 🧡 issaid.org/news.html#29 #autoinflammatory

Happy to see this out in @jhumimmunity. DADA2 has moved a long way from its first description as an early-onset stroke and vasculitis syndrome. In this review we take stock of where the field stands.
In a new review on DADA2, @IsabelleMeyts et al. cover the full spectrum of disease (vasculitis, bone marrow failure, immunodeficiency), TNF inhibitors, stem cell transplant, & #genetherapy on the horizon, the concept that a single variant can cause disease hubs.la/Q04rF_C20

.@bogunoviclab et al. show that, in a neonate with a DOCK11 variant of uncertain significance, negative functional studies guide clinical care, highlighting the broader value of publishing instructive negative findings in immunology & genomic medicine hubs.la/Q04n4Ht00

Kienapfel et al. report the characterization of two novel mutations underlying #STAT2 deficiency in three patients with viral infections & hyperinflammation following live viral vaccines. Beneficial use of ruxolinitib in one patient is also reported. hubs.la/Q04n4HK_0

Latest from us. :) Led by amazing Pat O’Connell. We, more often than not, see variants of unknown significance (VUSs), and by definition don’t know if they are causative of disease. The only way to exclude them as causative is to test them experimentally. doi.org/10.70962/jhi.2026005…

1/ Spotlighting our former trainee @alexyema - a clinician-scientist specializing in IEI and cellular therapies @ UCL Great Ormond Street Institute of Child Health (GOSICH). She is also an Honorary Consultant in Paediatric Immunology at Great Ormond Street Hospital (GOSH), London

New human inborn error of immunity! By identifying biallelic OSMR deficiency as a novel Primary Atopic Disorder, we uncover a previously unrecognized mechanism driving severe allergic disease and provide new insights into the biology of human atopy.
New human primary atopic disorder defined: @SimranKaurSamra and Sharma et al. @turveylab @UBC show OSMR deficiency disrupts OSM-STAT signaling, driving severe early-onset #eczema, #eosinophilia, and elevated IgE. hubs.la/Q04jcnX50 #Immunology #Genetics #Atopy #IEIs

New human primary atopic disorder defined: @SimranKaurSamra and Sharma et al. @turveylab @UBC show OSMR deficiency disrupts OSM-STAT signaling, driving severe early-onset #eczema, #eosinophilia, and elevated IgE. hubs.la/Q04jcnX50 #Immunology #Genetics #Atopy #IEIs

Fascinating and really cool 😎 study by @BogunovicLab in @jhumimmunity !
Latest from us. Led by amazing Azzeddine Tahiat. Novel forms of CD55 deficiency. Importantly, C5 inhibition restores B cell homeostasis #CHAPLE disease @KidsAtColumbia @ColumbiaPS @Columbia rupress.org/jhi/article/2/4/…

Earlier this month, the JMF team traveled to New Orleans for the Clinical Immunology Society (CIS) Annual Meeting, bringing together physicians, scientists, advocates, patients, and families from around the world to advance the future of clinical #immunology. During the meeting, JMF Scientific Director Jessica Quinn presented a poster highlighting findings from an upcoming publication on the Jeffrey’s Insights genetic sequencing program. We were proud to see our WINMD Grant recipients attending and presenting research posters at CIS. Supporting the next generation of researchers and innovators in immunology remains a vital part of JMF’s mission. While in New Orleans, we also hosted an in-person meeting of our Patient & Family Advisory Board (#PFAB), uniting patients and families affected by STAT1 GOF, STAT3 GOF, and JAK1 GOF to help create educational resources that truly reflect and amplify the patient experience. We are honored to continue supporting collaboration, research, education, and patient advocacy within the global PI community 💙 #CIS2026 #ClinicalImmunology #PrimaryImmunodeficiency #PICommunity #RareDisease #PatientAdvocacy #NOLA #JMFPFAB